Elevated fetal steroidogenic activity in autism

S Baron-Cohen; B Auyeung; B Nørgaard-Pedersen; D M Hougaard; M W Abdallah; L Melgaard; A S Cohen; B Chakrabarti; L Ruta; M V Lombardo

doi:10.1038/mp.2014.48

Elevated fetal steroidogenic activity in autism

S Baron-Cohen, B Auyeung, B Nørgaard-Pedersen, D M Hougaard, M W Abdallah, L Melgaard, A S Cohen, B Chakrabarti, L Ruta, M V Lombardo

School of Philosophy, Psychology and Language Sciences

Research output: Contribution to journal › Article › peer-review

Abstract

Autism affects males more than females, giving rise to the idea that the influence of steroid hormones on early fetal brain development may be one important early biological risk factor. Utilizing the Danish Historic Birth Cohort and Danish Psychiatric Central Register, we identified all amniotic fluid samples of males born between 1993 and 1999 who later received ICD-10 (International Classification of Diseases, 10th Revision) diagnoses of autism, Asperger syndrome or PDD-NOS (pervasive developmental disorder not otherwise specified) (n=128) compared with matched typically developing controls. Concentration levels of Δ4 sex steroids (progesterone, 17α-hydroxy-progesterone, androstenedione and testosterone) and cortisol were measured with liquid chromatography tandem mass spectrometry. All hormones were positively associated with each other and principal component analysis confirmed that one generalized latent steroidogenic factor was driving much of the variation in the data. The autism group showed elevations across all hormones on this latent generalized steroidogenic factor (Cohen’s d=0.37, P=0.0009) and this elevation was uniform across ICD-10 diagnostic label. These results provide the first direct evidence of elevated fetal steroidogenic activity in autism. Such elevations may be important as epigenetic fetal programming mechanisms and may interact with other important pathophysiological factors in autism.

Original language	English
Pages (from-to)	376-369
Number of pages	8
Journal	Molecular Psychiatry
Volume	20
Early online date	3 Jun 2014
DOIs	https://doi.org/10.1038/mp.2014.48
Publication status	Published - 31 Mar 2015

Access to Document

10.1038/mp.2014.48Licence: Creative Commons: Attribution (CC-BY)

mp201448a
This work is licensed under a Creative Commons Attribution 3.0 Unported License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/.
Final published version, 697 KBLicence: Creative Commons: Attribution (CC-BY)

Bonnie Auyeung
- bonnie.auyeunged.acuk
- School of Philosophy, Psychology and Language Sciences - Reader
- Edinburgh Neuroscience
Person: Academic: Research Active

Cite this

@article{c65573da68104c7fb6e095cfe160edd5,

title = "Elevated fetal steroidogenic activity in autism",

abstract = "Autism affects males more than females, giving rise to the idea that the influence of steroid hormones on early fetal brain development may be one important early biological risk factor. Utilizing the Danish Historic Birth Cohort and Danish Psychiatric Central Register, we identified all amniotic fluid samples of males born between 1993 and 1999 who later received ICD-10 (International Classification of Diseases, 10th Revision) diagnoses of autism, Asperger syndrome or PDD-NOS (pervasive developmental disorder not otherwise specified) (n=128) compared with matched typically developing controls. Concentration levels of Δ4 sex steroids (progesterone, 17α-hydroxy-progesterone, androstenedione and testosterone) and cortisol were measured with liquid chromatography tandem mass spectrometry. All hormones were positively associated with each other and principal component analysis confirmed that one generalized latent steroidogenic factor was driving much of the variation in the data. The autism group showed elevations across all hormones on this latent generalized steroidogenic factor (Cohen{\textquoteright}s d=0.37, P=0.0009) and this elevation was uniform across ICD-10 diagnostic label. These results provide the first direct evidence of elevated fetal steroidogenic activity in autism. Such elevations may be important as epigenetic fetal programming mechanisms and may interact with other important pathophysiological factors in autism.",

author = "S Baron-Cohen and B Auyeung and B N{\o}rgaard-Pedersen and Hougaard, {D M} and Abdallah, {M W} and L Melgaard and Cohen, {A S} and B Chakrabarti and L Ruta and Lombardo, {M V}",

year = "2015",

month = mar,

day = "31",

doi = "10.1038/mp.2014.48",

language = "English",

volume = "20",

pages = "376--369",

journal = "Molecular Psychiatry",

issn = "1359-4184",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Elevated fetal steroidogenic activity in autism

AU - Baron-Cohen, S

AU - Auyeung, B

AU - Nørgaard-Pedersen, B

AU - Hougaard, D M

AU - Abdallah, M W

AU - Melgaard, L

AU - Cohen, A S

AU - Chakrabarti, B

AU - Ruta, L

AU - Lombardo, M V

PY - 2015/3/31

Y1 - 2015/3/31

N2 - Autism affects males more than females, giving rise to the idea that the influence of steroid hormones on early fetal brain development may be one important early biological risk factor. Utilizing the Danish Historic Birth Cohort and Danish Psychiatric Central Register, we identified all amniotic fluid samples of males born between 1993 and 1999 who later received ICD-10 (International Classification of Diseases, 10th Revision) diagnoses of autism, Asperger syndrome or PDD-NOS (pervasive developmental disorder not otherwise specified) (n=128) compared with matched typically developing controls. Concentration levels of Δ4 sex steroids (progesterone, 17α-hydroxy-progesterone, androstenedione and testosterone) and cortisol were measured with liquid chromatography tandem mass spectrometry. All hormones were positively associated with each other and principal component analysis confirmed that one generalized latent steroidogenic factor was driving much of the variation in the data. The autism group showed elevations across all hormones on this latent generalized steroidogenic factor (Cohen’s d=0.37, P=0.0009) and this elevation was uniform across ICD-10 diagnostic label. These results provide the first direct evidence of elevated fetal steroidogenic activity in autism. Such elevations may be important as epigenetic fetal programming mechanisms and may interact with other important pathophysiological factors in autism.

AB - Autism affects males more than females, giving rise to the idea that the influence of steroid hormones on early fetal brain development may be one important early biological risk factor. Utilizing the Danish Historic Birth Cohort and Danish Psychiatric Central Register, we identified all amniotic fluid samples of males born between 1993 and 1999 who later received ICD-10 (International Classification of Diseases, 10th Revision) diagnoses of autism, Asperger syndrome or PDD-NOS (pervasive developmental disorder not otherwise specified) (n=128) compared with matched typically developing controls. Concentration levels of Δ4 sex steroids (progesterone, 17α-hydroxy-progesterone, androstenedione and testosterone) and cortisol were measured with liquid chromatography tandem mass spectrometry. All hormones were positively associated with each other and principal component analysis confirmed that one generalized latent steroidogenic factor was driving much of the variation in the data. The autism group showed elevations across all hormones on this latent generalized steroidogenic factor (Cohen’s d=0.37, P=0.0009) and this elevation was uniform across ICD-10 diagnostic label. These results provide the first direct evidence of elevated fetal steroidogenic activity in autism. Such elevations may be important as epigenetic fetal programming mechanisms and may interact with other important pathophysiological factors in autism.

U2 - 10.1038/mp.2014.48

DO - 10.1038/mp.2014.48

M3 - Article

SN - 1359-4184

VL - 20

SP - 376

EP - 369

JO - Molecular Psychiatry

JF - Molecular Psychiatry

ER -

Elevated fetal steroidogenic activity in autism

Abstract

Access to Document

Fingerprint

Profiles

Bonnie Auyeung

Cite this